SynAct Pharma’s SEK 150 Million Preferential Rights Offering

Baker McKenzie acted as legal advisor to the Joint Global Coordinators with an international Capital Markets, while Setterwalls has advised SynAct Pharma AB .SynAct Pharma executed a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here